2-38070996-T-C

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_000104.4(CYP1B1):​c.1358A>G​(p.Asn453Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.171 in 1,614,006 control chromosomes in the GnomAD database, including 25,836 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1623 hom., cov: 32)
Exomes 𝑓: 0.18 ( 24213 hom. )

Consequence

CYP1B1
NM_000104.4 missense

Scores

7
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 7.91

Publications

244 publications found
Variant links:
Genes affected
CYP1B1 (HGNC:2597): (cytochrome P450 family 1 subfamily B member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008]
CYP1B1 Gene-Disease associations (from GenCC):
  • CYP1B1-related glaucoma with or without anterior segment dysgenesis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • glaucoma 3A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P
  • anterior segment dysgenesis 6
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • congenital glaucoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Peters anomaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 35 curated pathogenic missense variants (we use a threshold of 10). The gene has 9 curated benign missense variants. Trascript score misZ: -2.0997 (below the threshold of 3.09). GenCC associations: The gene is linked to Peters anomaly, anterior segment dysgenesis 6, glaucoma 3A, CYP1B1-related glaucoma with or without anterior segment dysgenesis, congenital glaucoma.
BP4
Computational evidence support a benign effect (MetaRNN=0.0016258061).
BP6
Variant 2-38070996-T-C is Benign according to our data. Variant chr2-38070996-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 166969.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.205 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP1B1NM_000104.4 linkc.1358A>G p.Asn453Ser missense_variant Exon 3 of 3 ENST00000610745.5 NP_000095.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP1B1ENST00000610745.5 linkc.1358A>G p.Asn453Ser missense_variant Exon 3 of 3 1 NM_000104.4 ENSP00000478561.1

Frequencies

GnomAD3 genomes
AF:
0.130
AC:
19711
AN:
152108
Hom.:
1626
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0350
Gnomad AMI
AF:
0.0899
Gnomad AMR
AF:
0.134
Gnomad ASJ
AF:
0.163
Gnomad EAS
AF:
0.00462
Gnomad SAS
AF:
0.216
Gnomad FIN
AF:
0.148
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.184
Gnomad OTH
AF:
0.158
GnomAD2 exomes
AF:
0.153
AC:
38541
AN:
251460
AF XY:
0.164
show subpopulations
Gnomad AFR exome
AF:
0.0311
Gnomad AMR exome
AF:
0.114
Gnomad ASJ exome
AF:
0.166
Gnomad EAS exome
AF:
0.00337
Gnomad FIN exome
AF:
0.146
Gnomad NFE exome
AF:
0.186
Gnomad OTH exome
AF:
0.173
GnomAD4 exome
AF:
0.175
AC:
256523
AN:
1461780
Hom.:
24213
Cov.:
33
AF XY:
0.178
AC XY:
129501
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.0274
AC:
919
AN:
33480
American (AMR)
AF:
0.116
AC:
5180
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.163
AC:
4248
AN:
26136
East Asian (EAS)
AF:
0.00267
AC:
106
AN:
39700
South Asian (SAS)
AF:
0.229
AC:
19758
AN:
86256
European-Finnish (FIN)
AF:
0.146
AC:
7789
AN:
53420
Middle Eastern (MID)
AF:
0.184
AC:
1064
AN:
5768
European-Non Finnish (NFE)
AF:
0.186
AC:
207337
AN:
1111912
Other (OTH)
AF:
0.168
AC:
10122
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
12868
25735
38603
51470
64338
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7088
14176
21264
28352
35440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.129
AC:
19705
AN:
152226
Hom.:
1623
Cov.:
32
AF XY:
0.129
AC XY:
9579
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.0349
AC:
1451
AN:
41538
American (AMR)
AF:
0.134
AC:
2044
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.163
AC:
564
AN:
3468
East Asian (EAS)
AF:
0.00463
AC:
24
AN:
5188
South Asian (SAS)
AF:
0.216
AC:
1043
AN:
4830
European-Finnish (FIN)
AF:
0.148
AC:
1568
AN:
10596
Middle Eastern (MID)
AF:
0.184
AC:
54
AN:
294
European-Non Finnish (NFE)
AF:
0.185
AC:
12547
AN:
67996
Other (OTH)
AF:
0.155
AC:
328
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
870
1740
2610
3480
4350
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
240
480
720
960
1200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.164
Hom.:
10559
Bravo
AF:
0.124
TwinsUK
AF:
0.191
AC:
710
ALSPAC
AF:
0.177
AC:
682
ESP6500AA
AF:
0.0334
AC:
147
ESP6500EA
AF:
0.187
AC:
1608
ExAC
AF:
0.155
AC:
18793
Asia WGS
AF:
0.0880
AC:
307
AN:
3478
EpiCase
AF:
0.191
EpiControl
AF:
0.196

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 03, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 15958554, 11854439, 15486049, 23861929, 10426814, 24604202) -

Oct 01, 2016
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Glaucoma 3A Benign:2
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Anterior segment dysgenesis 6 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Glaucoma 3, primary infantile, B;C1856439:Glaucoma 3A;C4310623:Anterior segment dysgenesis 6 Benign:1
May 12, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital glaucoma Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.53
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.47
T;T;T
Eigen
Uncertain
0.38
Eigen_PC
Uncertain
0.47
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.82
.;T;D
MetaRNN
Benign
0.0016
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.0
M;.;M
PhyloP100
7.9
PrimateAI
Benign
0.29
T
Sift4G
Uncertain
0.0080
D;T;D
Vest4
0.089
ClinPred
0.012
T
GERP RS
6.0
Varity_R
0.30
gMVP
0.82
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800440; hg19: chr2-38298139; COSMIC: COSV52221635; COSMIC: COSV52221635; API